Spire Wealth Management Coh Bar, Inc. Transaction History

Spire Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$0.34 - $1.0 $697 - $2,050	-2,050 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$1.09 - $1.49 $1,049 - $1,434	-963 Reduced 31.96%	2,050 $3,000
Q1 2021 May 21, 2021	BUY	$1.26 - $2.02 $3,796 - $6,086	3,013 New	3,013 $4,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.